KMTS Stock — Kestra Medical Technologies, Ltd. Common Stock

Kestra Medical Technologies, Ltd. Common Stock (KMTS)

Updated October 16, 2026.

KMTS is a Stock. Total return is 24.7% over the past 1.6 years, 11.2 points behind SPY at 35.9%.

Kestra Medical Technologies operates as a wearable medical device and digital healthcare company focused on cardiovascular disease management. The company develops and commercializes its Cardiac Recovery System platform, which includes the ASSURE Wearable Cardioverter Defibrillator for continuous cardiac monitoring and automated therapy delivery, along with digital patient engagement tools designed to improve outcomes for patients at elevated risk of sudden cardiac arrest. The company does not currently have an established distribution history.

KMTS performance versus SPY

Price and return data through 2026-10-16.

Total return is 24.7% over the past 1.6 years, 11.2 points behind SPY at 35.9%. Over the past year its total return — price change plus distributions reinvested — is 17.1%. Its deepest 1-year drawdown was 36.2%.

KMTS key facts

Asset type

Stock

Asset class

Equity

Inception date

03/06/2025

Distribution frequency

None

Last close

$27.24 (as of 2026-10-16)

Market cap

$1,622,463,296

Average volume

521894.0

Payout ratio

0.0%

EPS

$-2.67

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

KMTS risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 36.2%.

Who may consider KMTS — and who may not

It is a weaker fit for investors who need monthly cash flow (KMTS does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on KMTS

• All tickers starting with K

Tagged: Healthcare.

Frequently asked questions